COPENHAGEN, May 3 (Reuters) - Denmark's Novo Nordisk , the world's biggest diabetes drug maker, reported forecast-beating operating profit for the first quarter and nudged up its 2017 operating profit growth outlook.
by reutersCOMPANYNEWS via Endless Supplies .Biz - News
No comments:
Post a Comment